Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ICUI logo ICUI
Upturn stock ratingUpturn stock rating
ICUI logo

ICU Medical Inc (ICUI)

Upturn stock ratingUpturn stock rating
$132.15
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: ICUI (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

6 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $186.2

1 Year Target Price $186.2

Analysts Price Target For last 52 week
$186.2Target price
Low$115.26
Current$132.15
high$196.26

Analysis of Past Performance

Type Stock
Historic Profit 12.99%
Avg. Invested days 43
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.24B USD
Price to earnings Ratio -
1Y Target Price 186.2
Price to earnings Ratio -
1Y Target Price 186.2
Volume (30-day avg) 6
Beta 0.89
52 Weeks Range 115.26 - 196.26
Updated Date 06/29/2025
52 Weeks Range 115.26 - 196.26
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.84

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -3.87%
Operating Margin (TTM) 4.89%

Management Effectiveness

Return on Assets (TTM) 1.79%
Return on Equity (TTM) -4.62%

Valuation

Trailing PE -
Forward PE 20.12
Enterprise Value 4555067535
Price to Sales(TTM) 1.34
Enterprise Value 4555067535
Price to Sales(TTM) 1.34
Enterprise Value to Revenue 1.88
Enterprise Value to EBITDA 16.35
Shares Outstanding 24611900
Shares Floating 23848229
Shares Outstanding 24611900
Shares Floating 23848229
Percent Insiders 3.04
Percent Institutions 101.8

Analyst Ratings

Rating 3
Target Price 186.2
Buy 2
Strong Buy 3
Buy 2
Strong Buy 3
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

ICU Medical Inc

stock logo

Company Overview

overview logo History and Background

ICU Medical Inc. was founded in 1984. Initially focused on needlefree IV connectors, it expanded through acquisitions and product development to become a leader in infusion therapy and critical care technologies. A significant milestone was the acquisition of Hospira Infusion Systems from Pfizer in 2017.

business area logo Core Business Areas

  • Infusion Systems: ICU Medical offers a comprehensive range of infusion pumps, dedicated administration sets, and solutions designed for medication delivery, fluid management, and patient monitoring.
  • IV Solutions: This segment provides a variety of IV solutions used for hydration, drug delivery, and nutritional support.
  • Medication Delivery: Offers a range of products for safe and efficient medication delivery, including closed system transfer devices (CSTD) and other safety-related technologies.

leadership logo Leadership and Structure

Vivek Jain serves as the Chief Executive Officer. The company has a traditional corporate structure with departments covering R&D, manufacturing, sales, marketing, finance, and regulatory affairs.

Top Products and Market Share

overview logo Key Offerings

  • IV Sets: IV sets are a core offering, with ICU Medical holding a significant portion of the market for certain specialized sets. Competitors include Baxter, B. Braun, and Smiths Medical. Market share data is fragmented and varies by specific IV set category.
  • Infusion Pumps: ICU Medical's infusion pumps are a key revenue driver. They compete with Baxter, B. Braun, and Medtronic in this space. Market share data is challenging to obtain precisely, but ICU Medical is a major player.
  • Closed System Transfer Devices (CSTD): These devices protect healthcare workers from hazardous drugs during compounding and administration. ICU Medical is a top competitor along with BD and Equashield. Market share data is fragmented and varies by specific region.

Market Dynamics

industry overview logo Industry Overview

The medical device industry is experiencing growth driven by an aging population, increasing chronic diseases, and technological advancements. Demand for infusion therapy and medication delivery systems continues to rise.

Positioning

ICU Medical holds a strong position in the infusion therapy market, particularly after the Hospira acquisition. Their competitive advantages include a broad product portfolio, established customer relationships, and a focus on safety and innovation.

Total Addressable Market (TAM)

The TAM for infusion therapy and related products is estimated to be in the tens of billions of dollars globally. ICU Medical is well-positioned to capture a significant share of this market.

Upturn SWOT Analysis

Strengths

  • Broad product portfolio
  • Established customer relationships
  • Strong presence in the infusion therapy market
  • Focus on safety and innovation

Weaknesses

  • Dependence on key products
  • Exposure to regulatory changes
  • Integration challenges from acquisitions
  • High debt level

Opportunities

  • Expanding into emerging markets
  • Developing new and innovative products
  • Acquiring complementary businesses
  • Growing demand for home infusion therapy

Threats

  • Intense competition
  • Pricing pressures
  • Product recalls
  • Changes in healthcare regulations

Competitors and Market Share

competitor logo Key Competitors

  • BAX
  • B Braun (Private)
  • BDX

Competitive Landscape

ICU Medical competes with larger players like Baxter and B. Braun. Its advantages include a specialized focus and a strong presence in certain market segments. Disadvantages may include limited scale compared to larger competitors.

Major Acquisitions

Hospira Infusion Systems

  • Year: 2017
  • Acquisition Price (USD millions): 900
  • Strategic Rationale: Expanded ICU Medical's product portfolio and market share in infusion therapy.

Growth Trajectory and Initiatives

Historical Growth: ICU Medical has experienced growth through acquisitions and organic expansion.

Future Projections: Future projections are based on analyst estimates, which are subject to change.

Recent Initiatives: Recent initiatives include product launches, strategic partnerships, and cost-reduction programs.

Summary

ICU Medical is a significant player in the infusion therapy market with a broad product portfolio. The Hospira acquisition strengthened its position, but integration and debt management remain challenges. Competition and regulatory changes pose ongoing threats, while emerging markets offer growth opportunities.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings (SEC)
  • Industry reports
  • Analyst estimates

Disclaimers:

This analysis is based on publicly available information and analyst estimates, which are subject to change. This is not financial advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About ICU Medical Inc

Exchange NASDAQ
Headquaters San Clemente, CA, United States
IPO Launch date 1992-03-31
CEO & Chairman of the Board Mr. Vivek Jain
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 15000
Full time employees 15000

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.